Back
MoonLake Immunotherapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
MLTX
MoonLake Immunotherapeutics
Last Price:
$13.88
Seasonality Move:
20.98%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and MLTX is experiencing slight buying pressure.
MoonLake Immunotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.92 | Sell |
| 20-day SMA: | 14.05 | Sell |
| 50-day SMA: | 12.22 | Buy |
| 200-day SMA: | 35.57 | Sell |
| 8-day EMA: | 13.86 | Buy |
| 20-day EMA: | 13.83 | Buy |
| 50-day EMA: | 16.3 | Sell |
| 200-day EMA: | 31.58 | Sell |
MoonLake Immunotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 49.49 | Sell |
| Chaikin Money Flow: | 13900 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.13 - 14.63) | Sell |
| Bollinger Bands (100): | (6.81 - 49.31) | Sell |
MoonLake Immunotherapeutics Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for MoonLake Immunotherapeutics Stock
Is MoonLake Immunotherapeutics Stock a Buy?
-
MoonLake Immunotherapeutics share price is 13.87 while MLTX 8-day simple moving average is 13.92, which is a Sell signal.
-
The stock price of MLTX is 13.87 while MoonLake Immunotherapeutics 20-day SMA is 14.05, which makes it a Sell.
-
MoonLake Immunotherapeutics 50-day simple moving average is 12.22 while MLTX share price is 13.87, making it a Buy technically.
-
MLTX stock price is 13.87 and MoonLake Immunotherapeutics 200-day simple moving average is 35.57, creating a Sell signal.
MLTX Technical Analysis vs Fundamental Analysis
Sell
38
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics a Buy or a Sell?
-
MoonLake Immunotherapeutics stock is rated a SellThe current MoonLake Immunotherapeutics [MLTX] share price is $13.87. The Score for MLTX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
MoonLake Immunotherapeutics Stock Info
Market Cap:
982.7M
Price in USD:
13.87
Share Volume:
536.5K
MoonLake Immunotherapeutics 52-Week Range
52-Week High:
62.75
52-Week Low:
5.95
Sell
38
MoonLake Immunotherapeutics (MLTX)
is a Sell
MoonLake Immunotherapeutics Share Price Forecast
-
What is the MoonLake Immunotherapeutics stock price today?The MoonLake Immunotherapeutics stock price is 13.87 USD today.
-
Will MLTX stock go up or go down?MoonLake Immunotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is MoonLake Immunotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, MoonLake Immunotherapeutics is overvalued.
Is MoonLake Immunotherapeutics Stock a Buy?
-
MoonLake Immunotherapeutics share price is 13.87 while MLTX 8-day exponential moving average is 13.86, which is a Buy signal.
-
The stock price of MLTX is 13.87 while MoonLake Immunotherapeutics 20-day EMA is 13.83, which makes it a Buy.
-
MoonLake Immunotherapeutics 50-day exponential moving average is 16.30 while MLTX share price is 13.87, making it a Sell technically.
-
MLTX stock price is 13.87 and MoonLake Immunotherapeutics 200-day simple moving average is 31.58, creating a Sell signal.
Fundamental Analysis of MoonLake Immunotherapeutics
Is MoonLake Immunotherapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.86 per share, and a decrease next year of $0.00 per share.
Technical Analysis of MoonLake Immunotherapeutics
Should I short MoonLake Immunotherapeutics stock?
-
MLTX Moving Average Covergence Divergence (MACD) indicator is -0, suggesting MoonLake Immunotherapeutics is a Sell
-
MoonLake Immunotherapeutics Relative Strength Index (RSI) is 49.49, which suggest MoonLake Immunotherapeutics is oversold
-
The Bollinger Bands (25) for MoonLake Immunotherapeutics is (13.13 - 14.63), which suggest MoonLake Immunotherapeutics is a Sell
-
The Bollinger Bands (100) for MoonLake Immunotherapeutics is (6.81 - 49.31), which suggest MoonLake Immunotherapeutics is a Sell
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.